Clinical Trials Browser

Porfiromycin × Clear all

NCT02209701 2014-08-06

Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors

Phase 1 Terminated

Head and Neck Neoplasms

NCT02183246 2014-07-08

Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

Phase 3 Terminated

Head and Neck Neoplasms

NCT00002507 2013-07-25

Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer

Phase 3 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Unknown Primary

NCT00003328 2010-05-21

Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 3 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms